Dr Emily F Richard, DNP, CRNA - Medicare Certified Registered Nurse Anesthetist (crna) in Jefferson, LA

Dr Emily F Richard, DNP, CRNA is a medicare enrolled "Nurse Anesthetist, Certified Registered" in Jefferson, Louisiana. She graduated from nursing school in 2019 and has 5 years of diverse experience with area of expertise as Certified Registered Nurse Anesthetist (crna). She is a member of the group practice Childrens Hospital Anesthesia Corporation, Ochsner Clinic Llc and her current practice location is 1514 Jefferson Hwy, Jefferson, Louisiana. You can reach out to her office (for appointments etc.) via phone at (504) 842-3000.

Dr Emily F Richard is licensed to practice in Louisiana (license number 206914) and she also participates in the medicare program. She accepts medicare assignments (which means she accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance) and her NPI Number is 1013577758.

Contact Information

Dr Emily F Richard, DNP, CRNA
1514 Jefferson Hwy,
Jefferson, LA 70121-2429
(504) 842-3000
Not Available



Provider's Profile

Full NameDr Emily F Richard
GenderFemale
SpecialityCertified Registered Nurse Anesthetist (crna)
Experience5 Years
Location1514 Jefferson Hwy, Jefferson, Louisiana
Accepts Medicare AssignmentsYes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance.
  Medical Education and Training:
  • Dr Emily F Richard graduated from nursing school in 2019
  NPI Data:
  • NPI Number: 1013577758
  • Provider Enumeration Date: 06/14/2019
  • Last Update Date: 07/08/2019
  Medicare PECOS Information:
  • PECOS PAC ID: 6901134592
  • Enrollment ID: I20190820003575

Medical Identifiers

Medical identifiers for Dr Emily F Richard such as npi, medicare ID, medicare PIN, medicaid, etc.
IdentifierTypeStateIssuer
1013577758NPI-NPPES

Medical Taxonomies and Licenses

TaxonomyTypeLicense (State)Status
367500000XNurse Anesthetist, Certified Registered 206914 (Louisiana)Primary

Medical Facilities Affiliation

Facility NameLocationFacility Type
Ochsner Clinic FoundationNew orleans, LAHospital

Group Practice Association

Group Practice NameGroup PECOS PAC IDNo. of Members
Childrens Hospital Anesthesia Corporation0446152862221
Ochsner Clinic Llc82249336192403

News Archive

Magnetoencephalography can be used to control and train specific targeted brain regions

A new brain-imaging technique enables people to 'watch' their own brain activity in real time and to control or adjust function in pre-determined brain regions. The study from the Montreal Neurological Institute and Hospital - The Neuro, McGill University and the McGill University Health Centre, published in NeuroImage, is the first to demonstrate that magnetoencephalography can be used as a potential therapeutic tool to control and train specific targeted brain regions.

Pathologists use ProExC antibody cocktail to determine tumor recurrence

Partnering with head and neck surgeons, pathologists at Dartmouth Hitchcock Medical Center's Norris Cotton Cancer Center developed a new use for an old test to determine if a patient's cancer is recurring, or if the biopsy shows benign inflammation of mucosal tissues. In Pathology - Research and Practice, lead author Candice C. Black, DO explained how her team confirmed the utility of ProExC, an existing antibody cocktail commonly used for pathology tests of the uterine cervix.

Healthcare systems integrator Evolutionary Systems awarded Oracle's Certified Advantage Partner status

Evolutionary Systems, (Evosys) a leading systems integrator for the healthcare and public sector industry, has been awarded Oracle's Certified Advantage Partner status by Oracle. To achieve this accreditation Evosys underwent a number of rigorous assessments, covering technical excellence, commercial capability and customer satisfaction.

Study identifies potential 'safe period' for hormone replacement use

A new study makes important new findings on the role of hormone use on the risk of breast cancer, confirming that the use of estrogen plus progesterone increases the risk of both ductal and lobular breast cancer far more than estrogen-only; suggesting a two-year 'safe' period for the use of estrogen and progesterone; and finding that the increased risk for ductal cancers observed in long-term past users of hormone replacement therapy drops off substantially two years after hormone use is stopped.

PolyU researchers create comprehensive breast milk nutrient database in Hong Kong

Breastfeeding has become more common all across the world in recent years, however, breastfeeding rate has remained low in Hong Kong. One of the main reasons is that Hong Kong mothers worry about the nutrient adequacy of their breast milk to meet the growing needs of the infant.

Read more Medical News

› Verified 3 days ago

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Medicare reassignment of benefits is a mechanism by which practitioners allow third parties to bill and receive payment for medicare services performed by them. Dr Emily F Richard allows following entities to bill medicare on her behalf.
Entity NameOchsner Clinic Llc
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1538151428
PECOS PAC ID: 8224933619
Enrollment ID: O20031126000513

News Archive

Magnetoencephalography can be used to control and train specific targeted brain regions

A new brain-imaging technique enables people to 'watch' their own brain activity in real time and to control or adjust function in pre-determined brain regions. The study from the Montreal Neurological Institute and Hospital - The Neuro, McGill University and the McGill University Health Centre, published in NeuroImage, is the first to demonstrate that magnetoencephalography can be used as a potential therapeutic tool to control and train specific targeted brain regions.

Pathologists use ProExC antibody cocktail to determine tumor recurrence

Partnering with head and neck surgeons, pathologists at Dartmouth Hitchcock Medical Center's Norris Cotton Cancer Center developed a new use for an old test to determine if a patient's cancer is recurring, or if the biopsy shows benign inflammation of mucosal tissues. In Pathology - Research and Practice, lead author Candice C. Black, DO explained how her team confirmed the utility of ProExC, an existing antibody cocktail commonly used for pathology tests of the uterine cervix.

Healthcare systems integrator Evolutionary Systems awarded Oracle's Certified Advantage Partner status

Evolutionary Systems, (Evosys) a leading systems integrator for the healthcare and public sector industry, has been awarded Oracle's Certified Advantage Partner status by Oracle. To achieve this accreditation Evosys underwent a number of rigorous assessments, covering technical excellence, commercial capability and customer satisfaction.

Study identifies potential 'safe period' for hormone replacement use

A new study makes important new findings on the role of hormone use on the risk of breast cancer, confirming that the use of estrogen plus progesterone increases the risk of both ductal and lobular breast cancer far more than estrogen-only; suggesting a two-year 'safe' period for the use of estrogen and progesterone; and finding that the increased risk for ductal cancers observed in long-term past users of hormone replacement therapy drops off substantially two years after hormone use is stopped.

PolyU researchers create comprehensive breast milk nutrient database in Hong Kong

Breastfeeding has become more common all across the world in recent years, however, breastfeeding rate has remained low in Hong Kong. One of the main reasons is that Hong Kong mothers worry about the nutrient adequacy of their breast milk to meet the growing needs of the infant.

Read more Medical News

› Verified 3 days ago

Entity NameLouisiana State University School Of Medicine In New Orleans Faculty G
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1477582526
PECOS PAC ID: 0244136448
Enrollment ID: O20031209000661

News Archive

Magnetoencephalography can be used to control and train specific targeted brain regions

A new brain-imaging technique enables people to 'watch' their own brain activity in real time and to control or adjust function in pre-determined brain regions. The study from the Montreal Neurological Institute and Hospital - The Neuro, McGill University and the McGill University Health Centre, published in NeuroImage, is the first to demonstrate that magnetoencephalography can be used as a potential therapeutic tool to control and train specific targeted brain regions.

Pathologists use ProExC antibody cocktail to determine tumor recurrence

Partnering with head and neck surgeons, pathologists at Dartmouth Hitchcock Medical Center's Norris Cotton Cancer Center developed a new use for an old test to determine if a patient's cancer is recurring, or if the biopsy shows benign inflammation of mucosal tissues. In Pathology - Research and Practice, lead author Candice C. Black, DO explained how her team confirmed the utility of ProExC, an existing antibody cocktail commonly used for pathology tests of the uterine cervix.

Healthcare systems integrator Evolutionary Systems awarded Oracle's Certified Advantage Partner status

Evolutionary Systems, (Evosys) a leading systems integrator for the healthcare and public sector industry, has been awarded Oracle's Certified Advantage Partner status by Oracle. To achieve this accreditation Evosys underwent a number of rigorous assessments, covering technical excellence, commercial capability and customer satisfaction.

Study identifies potential 'safe period' for hormone replacement use

A new study makes important new findings on the role of hormone use on the risk of breast cancer, confirming that the use of estrogen plus progesterone increases the risk of both ductal and lobular breast cancer far more than estrogen-only; suggesting a two-year 'safe' period for the use of estrogen and progesterone; and finding that the increased risk for ductal cancers observed in long-term past users of hormone replacement therapy drops off substantially two years after hormone use is stopped.

PolyU researchers create comprehensive breast milk nutrient database in Hong Kong

Breastfeeding has become more common all across the world in recent years, however, breastfeeding rate has remained low in Hong Kong. One of the main reasons is that Hong Kong mothers worry about the nutrient adequacy of their breast milk to meet the growing needs of the infant.

Read more Medical News

› Verified 3 days ago

Entity NameChildrens Hospital Anesthesia Corporation
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1649362740
PECOS PAC ID: 0446152862
Enrollment ID: O20040124000258

News Archive

Magnetoencephalography can be used to control and train specific targeted brain regions

A new brain-imaging technique enables people to 'watch' their own brain activity in real time and to control or adjust function in pre-determined brain regions. The study from the Montreal Neurological Institute and Hospital - The Neuro, McGill University and the McGill University Health Centre, published in NeuroImage, is the first to demonstrate that magnetoencephalography can be used as a potential therapeutic tool to control and train specific targeted brain regions.

Pathologists use ProExC antibody cocktail to determine tumor recurrence

Partnering with head and neck surgeons, pathologists at Dartmouth Hitchcock Medical Center's Norris Cotton Cancer Center developed a new use for an old test to determine if a patient's cancer is recurring, or if the biopsy shows benign inflammation of mucosal tissues. In Pathology - Research and Practice, lead author Candice C. Black, DO explained how her team confirmed the utility of ProExC, an existing antibody cocktail commonly used for pathology tests of the uterine cervix.

Healthcare systems integrator Evolutionary Systems awarded Oracle's Certified Advantage Partner status

Evolutionary Systems, (Evosys) a leading systems integrator for the healthcare and public sector industry, has been awarded Oracle's Certified Advantage Partner status by Oracle. To achieve this accreditation Evosys underwent a number of rigorous assessments, covering technical excellence, commercial capability and customer satisfaction.

Study identifies potential 'safe period' for hormone replacement use

A new study makes important new findings on the role of hormone use on the risk of breast cancer, confirming that the use of estrogen plus progesterone increases the risk of both ductal and lobular breast cancer far more than estrogen-only; suggesting a two-year 'safe' period for the use of estrogen and progesterone; and finding that the increased risk for ductal cancers observed in long-term past users of hormone replacement therapy drops off substantially two years after hormone use is stopped.

PolyU researchers create comprehensive breast milk nutrient database in Hong Kong

Breastfeeding has become more common all across the world in recent years, however, breastfeeding rate has remained low in Hong Kong. One of the main reasons is that Hong Kong mothers worry about the nutrient adequacy of their breast milk to meet the growing needs of the infant.

Read more Medical News

› Verified 3 days ago

Entity NameParish Anesthesia Of Tulane
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1588998231
PECOS PAC ID: 5496897753
Enrollment ID: O20100125000469

News Archive

Magnetoencephalography can be used to control and train specific targeted brain regions

A new brain-imaging technique enables people to 'watch' their own brain activity in real time and to control or adjust function in pre-determined brain regions. The study from the Montreal Neurological Institute and Hospital - The Neuro, McGill University and the McGill University Health Centre, published in NeuroImage, is the first to demonstrate that magnetoencephalography can be used as a potential therapeutic tool to control and train specific targeted brain regions.

Pathologists use ProExC antibody cocktail to determine tumor recurrence

Partnering with head and neck surgeons, pathologists at Dartmouth Hitchcock Medical Center's Norris Cotton Cancer Center developed a new use for an old test to determine if a patient's cancer is recurring, or if the biopsy shows benign inflammation of mucosal tissues. In Pathology - Research and Practice, lead author Candice C. Black, DO explained how her team confirmed the utility of ProExC, an existing antibody cocktail commonly used for pathology tests of the uterine cervix.

Healthcare systems integrator Evolutionary Systems awarded Oracle's Certified Advantage Partner status

Evolutionary Systems, (Evosys) a leading systems integrator for the healthcare and public sector industry, has been awarded Oracle's Certified Advantage Partner status by Oracle. To achieve this accreditation Evosys underwent a number of rigorous assessments, covering technical excellence, commercial capability and customer satisfaction.

Study identifies potential 'safe period' for hormone replacement use

A new study makes important new findings on the role of hormone use on the risk of breast cancer, confirming that the use of estrogen plus progesterone increases the risk of both ductal and lobular breast cancer far more than estrogen-only; suggesting a two-year 'safe' period for the use of estrogen and progesterone; and finding that the increased risk for ductal cancers observed in long-term past users of hormone replacement therapy drops off substantially two years after hormone use is stopped.

PolyU researchers create comprehensive breast milk nutrient database in Hong Kong

Breastfeeding has become more common all across the world in recent years, however, breastfeeding rate has remained low in Hong Kong. One of the main reasons is that Hong Kong mothers worry about the nutrient adequacy of their breast milk to meet the growing needs of the infant.

Read more Medical News

› Verified 3 days ago

Entity NameZephyr Anesthesia Llc
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1891087458
PECOS PAC ID: 1658559125
Enrollment ID: O20110705000180

News Archive

Magnetoencephalography can be used to control and train specific targeted brain regions

A new brain-imaging technique enables people to 'watch' their own brain activity in real time and to control or adjust function in pre-determined brain regions. The study from the Montreal Neurological Institute and Hospital - The Neuro, McGill University and the McGill University Health Centre, published in NeuroImage, is the first to demonstrate that magnetoencephalography can be used as a potential therapeutic tool to control and train specific targeted brain regions.

Pathologists use ProExC antibody cocktail to determine tumor recurrence

Partnering with head and neck surgeons, pathologists at Dartmouth Hitchcock Medical Center's Norris Cotton Cancer Center developed a new use for an old test to determine if a patient's cancer is recurring, or if the biopsy shows benign inflammation of mucosal tissues. In Pathology - Research and Practice, lead author Candice C. Black, DO explained how her team confirmed the utility of ProExC, an existing antibody cocktail commonly used for pathology tests of the uterine cervix.

Healthcare systems integrator Evolutionary Systems awarded Oracle's Certified Advantage Partner status

Evolutionary Systems, (Evosys) a leading systems integrator for the healthcare and public sector industry, has been awarded Oracle's Certified Advantage Partner status by Oracle. To achieve this accreditation Evosys underwent a number of rigorous assessments, covering technical excellence, commercial capability and customer satisfaction.

Study identifies potential 'safe period' for hormone replacement use

A new study makes important new findings on the role of hormone use on the risk of breast cancer, confirming that the use of estrogen plus progesterone increases the risk of both ductal and lobular breast cancer far more than estrogen-only; suggesting a two-year 'safe' period for the use of estrogen and progesterone; and finding that the increased risk for ductal cancers observed in long-term past users of hormone replacement therapy drops off substantially two years after hormone use is stopped.

PolyU researchers create comprehensive breast milk nutrient database in Hong Kong

Breastfeeding has become more common all across the world in recent years, however, breastfeeding rate has remained low in Hong Kong. One of the main reasons is that Hong Kong mothers worry about the nutrient adequacy of their breast milk to meet the growing needs of the infant.

Read more Medical News

› Verified 3 days ago

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Dr Emily F Richard is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing AddressPractice Location Address
Dr Emily F Richard, DNP, CRNA
4436 Rue Saint Peter,
Kenner, LA 70065-1139

Ph: () -
Dr Emily F Richard, DNP, CRNA
1514 Jefferson Hwy,
Jefferson, LA 70121-2429

Ph: (504) 842-3000

News Archive

Magnetoencephalography can be used to control and train specific targeted brain regions

A new brain-imaging technique enables people to 'watch' their own brain activity in real time and to control or adjust function in pre-determined brain regions. The study from the Montreal Neurological Institute and Hospital - The Neuro, McGill University and the McGill University Health Centre, published in NeuroImage, is the first to demonstrate that magnetoencephalography can be used as a potential therapeutic tool to control and train specific targeted brain regions.

Pathologists use ProExC antibody cocktail to determine tumor recurrence

Partnering with head and neck surgeons, pathologists at Dartmouth Hitchcock Medical Center's Norris Cotton Cancer Center developed a new use for an old test to determine if a patient's cancer is recurring, or if the biopsy shows benign inflammation of mucosal tissues. In Pathology - Research and Practice, lead author Candice C. Black, DO explained how her team confirmed the utility of ProExC, an existing antibody cocktail commonly used for pathology tests of the uterine cervix.

Healthcare systems integrator Evolutionary Systems awarded Oracle's Certified Advantage Partner status

Evolutionary Systems, (Evosys) a leading systems integrator for the healthcare and public sector industry, has been awarded Oracle's Certified Advantage Partner status by Oracle. To achieve this accreditation Evosys underwent a number of rigorous assessments, covering technical excellence, commercial capability and customer satisfaction.

Study identifies potential 'safe period' for hormone replacement use

A new study makes important new findings on the role of hormone use on the risk of breast cancer, confirming that the use of estrogen plus progesterone increases the risk of both ductal and lobular breast cancer far more than estrogen-only; suggesting a two-year 'safe' period for the use of estrogen and progesterone; and finding that the increased risk for ductal cancers observed in long-term past users of hormone replacement therapy drops off substantially two years after hormone use is stopped.

PolyU researchers create comprehensive breast milk nutrient database in Hong Kong

Breastfeeding has become more common all across the world in recent years, however, breastfeeding rate has remained low in Hong Kong. One of the main reasons is that Hong Kong mothers worry about the nutrient adequacy of their breast milk to meet the growing needs of the infant.

Read more News

› Verified 3 days ago


Nurse Anesthetist, Certified Registered Nurses in Jefferson, LA

Brandi Schnell, CRNA
Nurse Anesthetist - CR
Medicare: Accepting Medicare Assignments
Practice Location: 1514 Jefferson Hwy, Jefferson, LA 70121
Phone: 504-842-3755    Fax: 504-842-2036
Mr. Lee Allen Dennis Jr., CRNA
Nurse Anesthetist - CR
Medicare: Accepting Medicare Assignments
Practice Location: 1514 Jefferson Hwy, Jefferson, LA 70121
Phone: 504-842-9119    
Andrew Larkin,
Nurse Anesthetist - CR
Medicare: Accepting Medicare Assignments
Practice Location: 1514 Jefferson Hwy, Jefferson, LA 70121
Phone: 866-624-7637    
Dr. John Greer, DNP, CRNA
Nurse Anesthetist - CR
Medicare: Accepting Medicare Assignments
Practice Location: 1514 Jefferson Hwy, Jefferson, LA 70121
Phone: 504-842-3000    
Rebecca Johnson Krobert,
Nurse Anesthetist - CR
Medicare: Accepting Medicare Assignments
Practice Location: 1514 Jefferson Hwy, Jefferson, LA 70121
Phone: 504-842-3000    
Jenna Kelly, CRNA
Nurse Anesthetist - CR
Medicare: Accepting Medicare Assignments
Practice Location: 1514 Jefferson Hwy, Jefferson, LA 70121
Phone: 504-842-3000    

Find & Compare Providers Near You: Find and compare doctors, nursing homes, hospitals, and other health care providers in your area that accept Medicare. Get information like: Find a doctor or clinician that accepts Medicare near you.

Doctors and clinicians: Doctors and clinicians include doctors, clinicians and groups who are qualified to practice in many specialties. Each specialty focuses on certain parts of the body, periods of life, conditions, or primary care. The doctors, clinicians, and groups listed here typically work in an office or clinic setting. Also those who currently accept Medicare are included.

Hospitals: Find information about Medicare-certified hospitals and long-term care hospitals in your area, including Veterans Administration medical centers and military hospitals, across the country. Long-term care hospitals serve critically ill and medically complex patients who require extended hospital care.

Data provided: Information on www.medicareusa.org is built using open data sources published by Centers for Medicare & Medicaid Services (CMS) under Freedom of Information Act (FOIA).

© 2024 MedicareUsa. All rights reserved. Maintained by the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.